Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases [EARLY_Phase 1]
A Phase 0/1 study of GSK5764227, a B7-H3-targeted antibody-drug conjugate, in patients with recurrent grade 4 glioma (including glioblastoma…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma [Phase 1]
Phase 1 trial evaluating mesenchymal stem cell-delivered DNX-2401 for recurrent high-grade glioma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CUE-102 in Recurrent Glioblastoma [Phase 1]
Phase 1 clinical trial update for CUE-102 in recurrent glioblastoma showing the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma [Phase 1]
Phase 1 clinical trial evaluating IL13Ralpha2-CAR T cells for treating leptomeningeal metastasis, glioblastoma, ependymoma, and medulloblast…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]
Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas
This clinical trial update reports a comprehensive analysis of chemotherapy and targeted therapy outcomes in recurrent malignant gliomas, in…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Senicapoc and Perampanel for Newly Diagnosed Glioblastoma [EARLY_Phase 1]
This clinical trial update reports a Phase 1 study of combining senicapoc and perampanel for newly diagnosed glioblastoma, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Surgical Pembro +/- Olaparib w TMZ for rGBM [Phase 2]
Phase 2 clinical trial is recruiting to evaluate pembrolizumab with or without olaparib and temozolomide for recurrent glioblastoma, includi…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Methimazole in Patients With Progressive Glioblastoma [Phase 2]
Phase 2 clinical trial evaluating methimazole in progressive glioblastoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Effect of stRess and exeRcize on the Outcome After Chemo-Radiation
This clinical trial update reports the completion of a study assessing whether stress and exercise influence outcomes after chemo-radiation …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care [Phase 3]
Phase 3 trial evaluating immediate radiation with GammaTile at glioblastoma excision versus standard of care; currently recruiting.
-
CLINICAL_TRIALS other · 2026-03-04Clinical Trial Update: Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma [Phase 1, Phase 2]
Clinical trial update for an AAV-mediated dual-payload gene therapy in high-grade glioma; trial status is not yet recruiting (Phase 1/Phase …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Expanded Access to Gallium Maltolate (GaM)
Expanded access to Gallium maltolate (GaM) for glioblastoma is no longer available.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Supramarginal Resection in Glioblastoma [NA]
Ongoing clinical trial update for supramarginal resection in glioblastoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial sponsored by Neonc Technologies evaluating safety and efficacy of a therapy in recurrent or progressive Grade III…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Karyopharm Expanded Access Program for Selinexor
This update covers Karyopharm's Expanded Access Program for selinexor (Xpovio), including eligibility and current availability for listed ca…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Mind-Body Intervention in Glioma Couples [NA]
Clinical trial update for a mind-body intervention targeting glioma patients and their partners. The study is currently active but not recru…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: FCI-Glioblastoma Study
Clinical trial update indicates the FCI-Glioblastoma Study sponsored by the University of Aberdeen is not yet recruiting for glioblastoma (W…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) [Phase 1]
A Phase 1 trial evaluating the safety of combining 5-ALA with the CV01 ultrasound delivery system for sonodynamic therapy in patients with n…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. [Phase 2]
A Phase 2 clinical trial update for pre-radiation chemotherapy in newly diagnosed high-grade gliomas, including glioblastoma, astrocytoma, a…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume [NA]
The document reports a clinical trial evaluating limiting the glioblastoma clinical target volume during radiotherapy to improve outcomes an…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma [Phase 1, Phase 2]
This document reports a Phase I/II clinical trial evaluating IVONESCIMAB for recurrent glioblastoma that is currently recruiting. No results…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma [Phase 1]
Phase 1 clinical trial update on combining capecitabine with bevacizumab in patients with recurrent glioblastoma.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients [NA]
A clinical trial update for OT SMILE, a group occupational therapy intervention for patients with primary brain tumors, including glioblasto…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma [EARLY_Phase 1]
Early-phase clinical trial evaluating sonodynamic therapy with SONALA-001 or 5-ALA HCl combined with MRI-guided focused ultrasound for progr…